Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study
SPEED-COVID
SPEED-COVID
Sponsor study identifier
observational
150
1 country
1
Study Start
April 22, 2021
Actual (reported)Primary Completion
May 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The aim of this study is to evaluate the prevalence of COVID-19 among the residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), and the factors that are likely to influence this prevalence.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 22, 2021
Actual (reported)May 2, 2021
Actual (reported)May 4, 2021
Actual (reported)May 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
May 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
General prevalence of COVID-19
measures the prevalence of COVID-19 among the residents and geriatric inpatients, defined as resident and patients with positive serologic or RT-PCR test
Through the study completion, an average of 12 months
Number of asymptomatic residents/inpatients
Through study completion, an average of 12 months
Number of symptomatic residents/inpatients
Through study completion, an average of 12 months
Number of residents/inpatients with severe form of COVID-19 which led to an hospitalization
Through study completion, an average of 12 months
Number of residents/inpatients infected with COVID-19 and hospitalized in a critical care unit
Through study completion, an average of 12 months
Number of residents/inpatients infected with COVID-19 and deceased
Through study completion, an average of 12 months
Periodic testings and testings with characteristic symptoms occur
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), from march, 2020, to december, 2021, who are not opposed to participate in this study.
Centre Hospitalier Sud Essonne
Étampes, Essonne, 91150, France
Shidasp SIAMI, MD, PhD
Centre Hospitalier Sud Essonne
First Submitted
May 2, 2021
First Posted
May 4, 2021
Study Start
April 22, 2021
Actual (reported)Primary Completion
May 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
COVID-19 and Pregnancy: Placental and Immunological Impacts
Contact the study team to confirm eligibility.
Study Completion
May 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 4, 2021
Record last verified: 2021-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: